Dergiler / Türk Patoloji Dergisi / 2020 / Cilt: 36 - Sayı: 3

Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study

Sayfa
211–217
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Public awareness should therefore be increased and breast cancer shouldbe considered in the differential diagnosis especially in the presence of breast swelling and complaints related to the breast skin so that theappropriate biopsy can be obtained without delay.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To evaluate the pathological and radiological features, immunohistochemical profile and treatment methods of primary male breastcarcinoma cases diagnosed at our center.Material and Method: The pathology archive between 2006 and 2019 was reviewed and the data of 27 male patients diagnosed as primary breastcancer were retrospectively evaluated.Results: The age of the patients ranged between 40-86 years.
📊
Temel Bulgular & Veri:The left breast was involved in 17 patients.
💡
Sonuç & Katkı:Public awareness should therefore be increased and breast cancer shouldbe considered in the differential diagnosis especially in the presence of breast swelling and complaints related to the breast skin so that theappropriate biopsy can be obtained without delay.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2006 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To evaluate the pathological and radiological features, immunohistochemical profile and treatment methods of primary male breastcarcinoma cases diagnosed at our center.Material and Method: The pathology archive between 2006 and 2019 was reviewed and the data of 27 male patients diagnosed as primary breastcancer were retrospectively evaluated.Results: The age of the patients ranged between 40-86 years. The left breast was involved in 17 patients. The mean tumor diameter was 2.35± 1.09 cm. Of the 27 cases, 8 were dead and 19 were alive. The mean follow-up duration was 37.45 ± 24.84 months. The mean estimated lifeexpectancy was 65±14.7 months. The most common complaint was a swelling in the breast. The time interval between the onset of complaintsand admittance to hospital ranged from three months to two years. The most common histopathological diagnosis was invasive carcinoma - nospecial type. The most common surgical procedure was mastectomy with lymph node dissection. Nine patients had metastatic lymph nodes. Interms of the hormone profiles, 24 were Estrogen receptor positive, 21 were Progesterone receptor positive and six were Her2/neu positive. Threepatients had triple-negative tumors.Conclusion: Male breast carcinoma is a rare disease but its frequency has been increasing recently. As breast cancer is more commonly attributedto women, the diagnosis is usually delayed until later stages in males. Public awareness should therefore be increased and breast cancer shouldbe considered in the differential diagnosis especially in the presence of breast swelling and complaints related to the breast skin so that theappropriate biopsy can be obtained without delay.

🔖

Bu Makaleye Atıf Yap

KUŞ, M., BOLAT, F. A., HASBAY, B., AYTAÇ, H. Ö., POURBAGHER, A. (2022). Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study. Türk Patoloji Dergisi, Cilt: 36 - Sayı: 3, 211–217. https://ajindex.com/articles/640388

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Ferzoco RM, Ruddy KJ. The epidemiology of male breast cancer. Curr Oncol Rep. 2016;18(1):1
  2. Şimşek Ş, Çakmakçı M. Erkek meme kanseri. Turkish Journal of Surgery. 2005; 21:157-62
  3. Özgönül A, Yalçın M, Güldür ME, Bitiren M, Çeçe H, Metineren H, Uzunköy A. Erkek meme kanseri: 2 olgu sunumu. Journal of Breast Health. 2010;6:34-7
  4. Gündoğdu K, Uzunoğlu Y, Arslan Y, Dilek FH, Kahyaoğlu Z, Altıntoprak F. Erkek meme kanseri: 3 olgu sunumu. Cumhuriyet Med J 2013; Supplement: 22-6
  5. Yang Y, Li S, Liu G, Shao Z. Is core needle biopsy effective at diagnosing male breast lesions? Breast Cancer Research and Treatment. 2019;177:507-11
  6. İkizceli T, Gülşen G, İnsan A, Savaş Y, Erözgen F. Male breast cancer associated with Paget’s Disease: A case report. Medical Bulletin of Haseki. 2018;56:235-7
  7. Kaur RP, Kumar V, Shafi G, Vashistha R, Kulharia M, Munshi A. A study of mechanistic mapping of novel SNPs to male breast cancer. Med Oncol. 2019;36:70
  8. Kate S, Jose L, David D, Rohit B. Male Breast Cancer. A singleinstitution clinicopathologic and immunohistochemical study. American Journal of Clinical Pathology. 2017;147:110-9
  9. Ruddy KJ, Winer EP. Male breast cancer: Risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24:1434-43
  10. Alıcı S, Kösem M, Çalka Ö, Kotan Ç, Mercan R. Erkek meme karsinomu (Olgu Sunumu). Turkish Archives of Dermatology and Venereology. 2003;37:117-9
  11. De La Cruz LM, Thiruchelvam PTR, Shivani J, Trina J, Blankenship SA, Fisher CS. Saving the male breast: A systematic literature review of breast-conservation surgery for male breast cancer. Ann Surg Oncol. 2019;26:3939-44
  12. Yetkin G, Mustafa Celayir MF, Tanik C, Citgez B, Uludag M, Mihmanli M. Male breast cancer: A 10 year retrospective case series in a tertiary care hospital. J Pak Med Assoc. 2019;69:1209- 12
  13. Tatar C, Erözgen F, Akıncı M, Benek S, Kızılkaya C. Erkek meme kanserinde prevalans ve klinik deneyimlerimiz. The Medical Bulletin of Haseki. 2013;51:99-101
  14. Pasricha S, Kamboj M, Tanwar P, Gupta G, Panigrahi M, Sharma A, Durga G, Mehta A. Immunophenotyping of male breast cancer - Experience at a tertiary care centre. Indian J Pathol Microbiol. 2019;62:226-31
  15. Taşcı Hİ, Tekin A, Küçükkartallar T, Çakır M. Aksiller lenf nodunda metastazla ortaya çıkan erkek okkült meme kanseri. Selçuk Tıp Dergisi. 2016;32:28-9
  16. Agbroko SO, Rojas KE, Manasseh DM, Borgen P. Male DCIS diagnosed after use of over-the counter hormonal supplement. In